Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion type Assertion NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_head.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion evidence source_evidence_literature NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion SIO_000772 24018334 NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion wasDerivedFrom befree-20150227 NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.
- NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_assertion wasGeneratedBy ECO_0000203 NP743807.RAl71Mj651vcPlDIbPcTr62nWzHOMTtS_T4wqdthh39-M130_provenance.